AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11232690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1273
Study 9402351 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone combined with bismuth subsalicylate and amoxicillin
Number of subjects: 105
Study 9402351 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up endoscopy
Number of subjects: 105
Study 9402351 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for antibodies to H. pylori
Number of subjects: 105
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: Human atrial natriuretic peptide (hANP) levels in type 1 diabetic patients
Number of subjects: 83
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial blood pressure
Number of subjects: 83
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urinary albumin excretion
Number of subjects: 83
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: hANP levels and metabolic control
Number of subjects: 83
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal vs elevated urinary albumin excretion
Number of subjects: 83
Study 8219653 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased urinary albumin and alpha-1-microglobulin excretion
Number of subjects: 83
Study 3304705 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 30 mg
Number of subjects: 12
Study 3304705 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine 100 mg/kg
Number of subjects: 12
Study 3304705 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 12
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: House cleaning intervention (including instruction on proper technique and cleaning supplies) for 1 week
Number of subjects: 32
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing intervention (including instruction on proper technique and soaps) for 1 week
Number of subjects: 32
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (house cleaning and hand washing) for 1 week
Number of subjects: 32
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: House cleaning intervention (for women with exposure above the median at baseline)
Number of subjects: 32
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing intervention (for women with exposure above the median at baseline)
Number of subjects: 32
Study 29950671 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (for women with exposure above the median at baseline)
Number of subjects: 32
Study 27140941 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated-sprint training in hypoxia (RSH, FiO2 = 13.8%)
Number of subjects: 15
Study 27140941 — intervention group
Group type: COMPARATOR
Intervention: Repeated-sprint training in normoxia (RSN, FiO2 = 20.9%)
Number of subjects: 15
Study 26468063 — intervention group
Group type: EXPERIMENTAL
Intervention: MOA-III
Number of subjects: 36
Study 26468063 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 36
Study 23958608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 10 minutes
Number of subjects: 99
Study 23958608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 20 minutes
Number of subjects: 99
Study 23958608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice pack therapy for 30 minutes
Number of subjects: 99
Study 23958608 — intervention group
Group type: COMPARATOR
Intervention: Pretest measurements
Number of subjects: 99
Study 21837837 — intervention group
Group type: EXPERIMENTAL
Intervention: Various physiotherapeutic modalities
Number of subjects: 0
Study 18996379 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with porfimer sodium combined with acid suppression (PHOPDT)
Number of subjects: 208
Study 18996379 — intervention group
Group type: COMPARATOR
Intervention: 20 mg omeprazole twice daily (control)
Number of subjects: 208
Study 16670912 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 252
Study 16670912 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 252
Study 15449078 — intervention group
Group type: EXPERIMENTAL
Intervention: COREFO questionnaire
Number of subjects: 257
Study 15449078 — intervention group
Group type: EXPERIMENTAL
Intervention: Hallbook questionnaire
Number of subjects: 257
Study 15449078 — intervention group
Group type: COMPARATOR
Intervention: Vaizey questionnaire
Number of subjects: 257
Study 10999815 — intervention group
Group type: EXPERIMENTAL
Intervention: rhLH, 900 IU/day sc
Number of subjects: 6
Study 10999815 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFSH, 150 IU/day sc
Number of subjects: 6
Study 10999815 — intervention group
Group type: EXPERIMENTAL
Intervention: rhLH plus rhFSH
Number of subjects: 6
Study 10999815 — intervention group
Group type: COMPARATOR
Intervention: rhFSH
Number of subjects: 6
Study 10999815 — intervention group
Group type: COMPARATOR
Intervention: rhLH
Number of subjects: 6
Study 9282238 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 30
Study 9282238 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30
Study 9282238 — intervention group
Group type: COMPARATOR
Intervention: Halothane (experimental rabbits)
Number of subjects: 30
Study 8378890 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast‐preserving therapy (BCT)
Number of subjects: 0
Study 8378890 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy without postoperative irradiation
Number of subjects: 0
Study 8378890 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative irradiation after tumorectomy
Number of subjects: 0
Study 8378890 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 0
Study 2439818 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol
Number of subjects: 24
Study 3137593 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.125 microgram/kg/min)
Number of subjects: 6
Study 3137593 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.25 microgram/kg/min)
Number of subjects: 6
Study 3137593 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicotine (0.5 microgram/kg/min)
Number of subjects: 6
Study 3137593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31910432 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP-methylation combinations associated with SCZ
Number of subjects: 15
Study 31910432 — intervention group
Group type: EXPERIMENTAL
Intervention: Convergent functional genomics method
Number of subjects: 15
Study 31218860 — intervention group
Group type: EXPERIMENTAL
Intervention: Icon infiltrant resin
Number of subjects: 40
Study 31218860 — intervention group
Group type: COMPARATOR
Intervention: Filtek Z250, Filtek Z350 XT, Beautiful Flow Plus F00
Number of subjects: 40
Study 29032110 — intervention group
Group type: EXPERIMENTAL
Intervention: CXL graft group (Group 1)
Number of subjects: 116
Study 29032110 — intervention group
Group type: COMPARATOR
Intervention: Conventional graft group (Group 2)
Number of subjects: 116
Study 26171733 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartQuit smartphone app
Number of subjects: 98
Study 23190756 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate amount of dairy food (AD), equivalent to ≥711 mL/d milk
Number of subjects: 51
Study 23190756 — intervention group
Group type: COMPARATOR
Intervention: Low amount of dairy food (LD), equivalent to ≤238 mL/d milk
Number of subjects: 51
Study 23190756 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restriction
Number of subjects: 51
Study 22097203 — intervention group
Group type: COMPARATOR
Intervention: Calcichew D3 Tablet
Number of subjects: 135
Study 22097203 — intervention group
Group type: COMPARATOR
Intervention: Calcichew D3 Tablet and Xianling Gubao Capsule
Number of subjects: 135
Study 22097203 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcichew D5 Tablet and embedding thread according to staging and wholism syndrome differentiation
Number of subjects: 135
Study 19541504 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (220 mg zinc sulfate capsule)
Number of subjects: 55
Study 19541504 — intervention group
Group type: COMPARATOR
Intervention: Placebo (220 mg corn starch)
Number of subjects: 55
Study 16274713 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat therapy (50 degrees C for 30s, applied once)
Number of subjects: 0
Study 16274713 — intervention group
Group type: COMPARATOR
Intervention: Glucantime therapy (antimonial, administered for 20 days)
Number of subjects: 0
Study 16274713 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat therapy
Number of subjects: 0
Study 16274713 — intervention group
Group type: COMPARATOR
Intervention: Glucantime therapy
Number of subjects: 0
Study 15467324 — intervention group
Group type: EXPERIMENTAL
Intervention: Respimat SMI
Number of subjects: 660
Study 15467324 — intervention group
Group type: COMPARATOR
Intervention: CFC-MDI
Number of subjects: 660
Study 11081698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued comprehension strategies
Number of subjects: 220
Study 9028548 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms/kg/day G-CSF
Number of subjects: 57
Study 9028548 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms/kg/day G-CSF
Number of subjects: 57
Study 9028548 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 micrograms/kg/day G-CSF
Number of subjects: 57
Study 9028548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of G-CSF
Number of subjects: 57
Study 9028548 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of G-CSF
Number of subjects: 57
Study 8103267 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototrichogram
Number of subjects: 12
Study 3511405 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bromocriptine (15 mg daily)
Number of subjects: 21
Study 3511405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 27781390 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent nutritional supplement for 24 weeks
Number of subjects: 194
Study 27781390 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 194
Study 27079964 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin T
Number of subjects: 128
Study 27079964 — intervention group
Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide
Number of subjects: 128
Study 24304938 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs), n = 401
Number of subjects: 895
Study 24304938 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 895
Study 22729115 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified GVL blade with a tube conduit
Number of subjects: 60
Study 22729115 — intervention group
Group type: COMPARATOR
Intervention: Conventional GVL blade and rigid intubating stylet
Number of subjects: 60
Study 19398145 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention of keratinocyte carcinomas (specific intervention details not provided)
Number of subjects: 931
Study 19398145 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher actinic keratoses (AK) count
Number of subjects: 931
Study 19398145 — intervention group
Group type: EXPERIMENTAL
Intervention: Past 5-fluorouracil (5-FU) use
Number of subjects: 931
Study 19398145 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher comorbidities
Number of subjects: 931
Study 19398145 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of previous KCs
Number of subjects: 931
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR with automated external defibrillators (AEDs)
Number of subjects: 19320
Study 17118512 — intervention group
Group type: COMPARATOR
Intervention: CPR-only
Number of subjects: 19320
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous emergency training
Number of subjects: 19320
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervisory/management or security personnel
Number of subjects: 19320
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous CPR training
Number of subjects: 19320
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous experience in emergency care
Number of subjects: 19320
Study 17118512 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education beyond high school
Number of subjects: 19320
Study 15688687 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementing the kidney and invigorating blood flow
Number of subjects: 248
Study 15688687 — intervention group
Group type: COMPARATOR
Intervention: Western drugs
Number of subjects: 248
Study 12494409 — intervention group
Group type: EXPERIMENTAL
Intervention: Amicus
Number of subjects: 20
Study 12494409 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectra
Number of subjects: 20
Study 12494409 — intervention group
Group type: EXPERIMENTAL
Intervention: CS3000+
Number of subjects: 20
Study 12494409 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS Plus
Number of subjects: 20
Study 10619639 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal face
Number of subjects: 0
Study 10619639 — intervention group
Group type: COMPARATOR
Intervention: Scattered face
Number of subjects: 0
Study 7776159 — intervention group
Group type: EXPERIMENTAL
Intervention: Device 1 (D-1)
Number of subjects: 9
Study 7776159 — intervention group
Group type: EXPERIMENTAL
Intervention: Device 2 (D-2)
Number of subjects: 9
Study 7776159 — intervention group
Group type: EXPERIMENTAL
Intervention: Day to day variation
Number of subjects: 9
Study 7776159 — intervention group
Group type: EXPERIMENTAL
Intervention: Menstrual cycle effect
Number of subjects: 9
Study 7776159 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking habit effect
Number of subjects: 9
Study 1970107 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) measurement
Number of subjects: 9
Study 1970107 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenocorticotropin (ACTH) measurement
Number of subjects: 9
Study 1970107 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolactin measurement
Number of subjects: 9
Study 1970107 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone measurement
Number of subjects: 9
Study 1970107 — intervention group
Group type: EXPERIMENTAL
Intervention: LH and FSH measurement
Number of subjects: 9
Study 7428415 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotrimazole (200 mg vaginal tablets)
Number of subjects: 111
Study 7428415 — intervention group
Group type: COMPARATOR
Intervention: Econazole (150 mg vaginal ovules)
Number of subjects: 111
Study 31317694 — intervention group
Group type: EXPERIMENTAL
Intervention: Frankincense consumption (500 mg pills, two times a day for 4 weeks)
Number of subjects: 20
Study 31317694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27808536 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 113
Study 27808536 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE)
Number of subjects: 113
Study 26745694 — intervention group
Group type: EXPERIMENTAL
Intervention: Iniparib 8 mg/kg intravenously on days 1 and 4 weekly
Number of subjects: 12
Study 25065093 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 ml 10% CHO drink preoperative night and 2 hours before anesthesia
Number of subjects: 100
Study 25065093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CHO drink)
Number of subjects: 100
Study 22085803 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based version of the Community Reinforcement Approach, in addition to prize-based contingency management
Number of subjects: 500
Study 22085803 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 500
Study 20384013 — intervention group
Group type: EXPERIMENTAL
Intervention: International assistant referees (ARs)
Number of subjects: 0
Study 20384013 — intervention group
Group type: COMPARATOR
Intervention: National assistant referees (ARs)
Number of subjects: 0
Study 17973781 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 28
Study 17973781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 15459842 — intervention group
Group type: EXPERIMENTAL
Intervention: PGF(2alpha) analogues (n = 78)
Number of subjects: 403
Study 15459842 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonic anhydrase inhibitors (n = 26)
Number of subjects: 403
Study 15459842 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PGF(2alpha) analogues and carbonic anhydrase inhibitors (n = 41)
Number of subjects: 403
Study 15459842 — intervention group
Group type: COMPARATOR
Intervention: None of these drugs (n = 258)
Number of subjects: 403
Study 11665499 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic educational programme
Number of subjects: 40
Study 11665499 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma school programme
Number of subjects: 40
Study 10346660 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of strength training
Number of subjects: 24
Study 10346660 — intervention group
Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 24
Study 10346660 — intervention group
Group type: COMPARATOR
Intervention: Other control condition (Control)
Number of subjects: 24
Study 7978476 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration
Number of subjects: 32
Study 7978476 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 2686424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin (200 mg every 12 hours)
Number of subjects: 60
Study 2686424 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftazidime (1 g every eight hours)
Number of subjects: 60
Study 2686424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin
Number of subjects: 60
Study 2686424 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 60
Study 4627093 — intervention group
Group type: EXPERIMENTAL
Intervention: disodium cromoglycate with isoprenaline
Number of subjects: 53
Study 4627093 — intervention group
Group type: COMPARATOR
Intervention: lactose with isoprenaline (placebo)
Number of subjects: 53
Study 30594886 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led asthma self-management program (n=35, ages 16-20 years)
Number of subjects: 259
Study 30594886 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led asthma self-management program
Number of subjects: 259
Study 30594886 — intervention group
Group type: COMPARATOR
Intervention: Healthcare professionals (control group)
Number of subjects: 259
Study 28646976 — intervention group
Group type: EXPERIMENTAL
Intervention: REDI‐P (16‐session home‐visiting intervention)
Number of subjects: 200
Study 28646976 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 28646976 — intervention group
Group type: EXPERIMENTAL
Intervention: REDI‐P
Number of subjects: 200
Study 25147345 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic preconditioning
Number of subjects: 18
Study 25147345 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 18
Study 22182228 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (dl‐alpha‐tocopherol acetate)
Number of subjects: 20
Study 22182228 — intervention group
Group type: COMPARATOR
Intervention: Control (non-supplemented buffaloes)
Number of subjects: 20
Study 22182228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (VeC and CC)
Number of subjects: 20
Study 22332049 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity and nutrition environmental intervention
Number of subjects: 13
Study 22332049 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 13
Study 19327425 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (E)
Number of subjects: 50
Study 19327425 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (C)
Number of subjects: 50
Study 16776698 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline infusion
Number of subjects: 20
Study 15562199 — intervention group
Group type: EXPERIMENTAL
Intervention: HIM2 (0.125 mg/kg)
Number of subjects: 6
Study 15562199 — intervention group
Group type: EXPERIMENTAL
Intervention: HIM2 (0.5 mg/kg)
Number of subjects: 6
Study 15562199 — intervention group
Group type: EXPERIMENTAL
Intervention: HIM2 (0.75 mg/kg)
Number of subjects: 6
Study 15562199 — intervention group
Group type: COMPARATOR
Intervention: HIM2 and lispro insulin
Number of subjects: 6
Study 11750294 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management programme
Number of subjects: 27
Study 11750294 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 subjects who did not participate in stress management)
Number of subjects: 27
Study 9430857 — intervention group
Group type: EXPERIMENTAL
Intervention: Loop diuretics (torasemide, frusemide)
Number of subjects: 92
Study 9430857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 9430857 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-oliguric patients
Number of subjects: 92
Study 9430857 — intervention group
Group type: EXPERIMENTAL
Intervention: Oliguric patients
Number of subjects: 92
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg, maximum 150 mg)
Number of subjects: 98
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (7 mg/kg)
Number of subjects: 98
Study 7900662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide vs Placebo
Number of subjects: 98
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 98
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 98
Study 7900662 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 98
Study 2693180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen procedure
Number of subjects: 52
Study 2693180 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet procedure
Number of subjects: 52